gadopentetate dimeglumine


Also found in: Wikipedia.

gadopentetate dimeglumine

 [gad″o-pen´tĕ-tāt di-meg´loo-mēn]
a paramagnetic agent used as a contrast agent in magnetic resonance imaging of intracranial, spinal, and associated lesions.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.
References in periodicals archive ?
Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2005 Feb;234(2):399-408.
Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients.
The conventional method is to infuse ultrasound gel or oral gadopentetate dimeglumine and polyethylene glycol to fill the rectum.
Gadopentetate dimeglumine contrast (Magnevist; Schering, Berlin, and Germany) in all the patients was administered intravenously at a weight-based dosing of 0.2 ml/kg with a bolus injection rate of 2 ml/sec using an automatic injector, which was followed by a 20-ml saline bolus injection.
Gadopentetate dimeglumine (Magnevist[R], Bayer Pharma, Gd-DTPA) is a MRI contrast agent that diffuses exclusively into the extracellular space of the liver [8].
When necessary, magnetic resonance imaging (MRI) was performed with liver specific MRI contrast agents, including gadopentetate dimeglumine (Magnevist[R]; Bayer Pharmaceuticals) and Gadoxetate disodium (Primovist[R], Bayer Pharmaceuticals) used at the discretion of the radiologist.
Data acquisition was initiated simultaneously with intravenous injection gadopentetate dimeglumine (Magnevist, Bayer Healthcare, Leverkusen; 0.1mmol/kg at 6 mL/s) followed by a 20 mL saline flush, injected at a rate of 2 mL/s.
Gadopentetate dimeglumine enhanced sagittal and axial (SE) T1W (TR, 450-600 msec; TE, 15-20 msec) images were obtained in all patients of intradural tumours.
Patients in this study were injected with intravenous gadopentetate dimeglumine during imaging of their elbows.
He subsequently underwent a CT scan of the abdomen and pelvis with oral contrast (OMNIPAQUE 300 milliliters), a radiographic bone survey, and a contrast (MAGNEVIST (Gadopentetate Dimeglumine) 15 milliliters) enhanced MR of the brain and orbits.
Kaewlai, "Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections," American Journal of Roentgenology, vol.
The second was a 363-patient Pan-Asian Phase III trial with 120 Japanese patients, which indicated non-inferiority of gadobutrol-enhanced MR images of the body (breast, heart, abdomen, kidney, pelvis and extremity) to those obtained through the use of gadopentetate dimeglumine.